These findings uncover a novel part of FBXO32 in HCC, implying that FBXO32 upregulation in HCC cells decreases PHLPP2 levels, further increasing p‐AKT levels and promoting tumor malignancy. The gene discussed is AKT1; the disease is neoplasm.